This week, on Street Check, Chris and Brad discuss early earnings season results and the impact (if any) they’re having on the market. Then they talk Eli Lilly (LLY) and Novo Nordisk’s (NVO) blockbuster weight loss drugs and what knock-on effects they could have on other stocks and sectors. To close out the podcast, they briefly touch on the situation in Gaza and the potential impact on investors before discussing Brad’s trip to Japan and (more importantly) the value of a favorable exchange rate when ticking items off your travel bucket list, whether Japan has turned the corner and is now a good investing destination, as well as a Japanese stock pick to take advantage of a recovering travel sector. Email Street Check at firstname.lastname@example.org with feedback, comments, or suggestions.
Get It While It’s Hot!
Be among the first to listen to Cabot Street Check when it comes out. Have it delivered right to your inbox every Saturday. Get on the list:
Along with your weekend video, you will receive our free weekday advisory, Cabot Wealth Daily, with top stock picks, market news and insightful commentary from our analysts.